Riskpilot← Back to searchSign inGet full accessCape Medical AB
ABActiveOrg 5563775922Kvarnstensgränd 2Medical specialists activities · NACE 8622Est. 19890 employees
Revenue 2025
SEK 1,3M
EBITDA margin
94.0%
+3333% vs 2024
Equity ratio
70.1%
Financial strength
Net profit 2025
SEK 545K
+7620% vs 2024
| Revenue | SEK 1,3M | — |
| EBITDA | SEK 1,2M | +3333% |
| Net profit | SEK 545K | +7620% |
| Total assets | SEK 2,1M | -1% |
| Equity | SEK 1,5M | +58% |
| Employees | 0 | — |
Legal name
Cape Medical AB
Org number
5563775922
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
3 december 1989
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva medicinsk verksamhet, dagligvaruhandel, handel med och förvaltning av värdepapper, fastighetsförvaltning, samt därmed förenlig verksamhet.
Address
Kvarnstensgränd 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 363 | 0 | 0 | 0 | 1 290 |
| Staff expenses | — | — | — | −0 | −0 |
| EBITDA | 191 | −90 | −33 | −38 | 1 213 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 191 | −90 | −33 | −38 | 1 213 |
| Net financials | 498 | −2 | −1 | −24 | −27 |
| Profit before tax | 1 030 | 557 | 66 | 9 | 686 |
| Tax | −114 | −115 | −14 | −1 | −141 |
| Net profit | 916 | 442 | 52 | 7 | 545 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 485 | 3 193 | 2 734 | 2 146 | 2 114 |
| Equity | 2 887 | 2 079 | 1 131 | 938 | 1 483 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 598 | 1 115 | 1 603 | 1 208 | 632 |
| Total debt | 598 | 1 115 | 1 603 | 1 208 | 632 |
EBITDA margin
94.0%
This company
15.8%
Market median
+495% vs market
20212025
Equity ratio
70.1%
This company
38.2%
Market median
+84% vs market
20212025
Return on equity
36.7%
This company
18.4%
Market median
+99% vs market
20212025
Net profit margin
42.2%
This company
8.1%
Market median
+421% vs market
20212025
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20212025
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CW Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Cape Medical AB 
Table Mountain Investment ABBoard members of Cape Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claes Wilhelm Hallengren | Chief Executive Officer | 0 companies |
| Berthe-Josephine Hallengren | Deputy Board Member | 0 companies |